Skip to main content

CASE REPORT article

Front. Oncol.

Sec. Thoracic Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1565549

This article is part of the Research Topic Lung Adenocarcinoma: From Genomics to Immunotherapy, Volume II View all 9 articles

Bronchiolar Adenoma with EGFR Exon 19 Del Mutation: A Case Report and Literature Review

Provisionally accepted
Shaobo Zhang Shaobo Zhang 1Xiaohui Liu Xiaohui Liu 2Xiaoxia Zhang Xiaoxia Zhang 3Peng Zhang Peng Zhang 4Haiming Feng Haiming Feng 1Peng Jiang Peng Jiang 1*
  • 1 Department of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu Province, China
  • 2 Department of Burns and Plastic Surgery & Wound Repair Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
  • 3 Department of Clinical Laboratory, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
  • 4 Department of Pathology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China

The final, formatted version of the article will be published soon.

    Background: Bronchiolar adenoma (BA) is a benign lung tumor characterized by nodular proliferation of bilayered bronchiolar-type epithelium with a continuous basal cell layer. The genetic characteristics of BA are not well understood. However, mutations commonly associated with lung adenocarcinoma, such as BRAF V600E, epidermal growth factor receptor (EGFR) mutations, and ALK rearrangements, have recently been identified in this context(1-8).Case report: This report describes a case of BA in a 43-year-old male who presented with a mixed ground-glass opacity (mGGO) detected during a routine physical examination. The patient had excellent cardiopulmonary function and no other medical conditions. After evaluation, local surgical resection was performed. Intraoperative frozen section pathology initially suggested adenocarcinoma. However, postoperative immunohistochemical examination confirmed the diagnosis of BA. Next-generation sequencing (NGS) further revealed an EGFR exon 19 deletion mutation.Conclusion: The histological morphology of highly differentiated small invasive adenocarcinomas and microinvasive adenocarcinomas closely resembles that of BAs in intraoperative frozen sections. Additionally, gene mutations linked to adenocarcinoma have been identified in BAs. The potential relationship between these two diseases warrants further investigation.

    Keywords: case report, Bronchiolar adenoma (BA), mixed Ground-glass opacity (mGGO), epidermal growth factor receptor (EGFR), gene mutation

    Received: 23 Jan 2025; Accepted: 21 Mar 2025.

    Copyright: © 2025 Zhang, Liu, Zhang, Zhang, Feng and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Peng Jiang, Department of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more